Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism BRPF1 inhibitors(bromodomain and PHD finger containing 1 inhibitors), BRPF2 inhibitors(bromodomain containing 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H17N3O4S |
InChIKeyUEMQPCYDWCSVCU-UHFFFAOYSA-N |
CAS Registry1883548-89-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | GB | 24 Aug 2017 |